Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

The 2015 BIO International Convention, for global biotech community, recently was held at the Pennsylvania Convention Center in Philadelphia and hosted 29,279 partnering meetings, a new record for the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The annual BIO International conference is large. Very ...

BOSTON, April 6, 2026 /PRNewswire/ -- As artificial intelligence moves from experimentation to execution in life sciences, the 25th Annual Bio-IT World Conference & Expo will spotlight how ...

BOSTON, March 5, 2026 /PRNewswire/ -- Cambridge Healthtech Institute today announced the agenda for the third annual Bio-IT World Venture, Innovation & Partnering Conference, an exclusive gathering of ...

A rendering of buildings planned for the downtown Research and Development District. Courtesy of IQHQ/Transparent House Premier biotech companies, investors, and industry talent from all over the ...

MIAMI, May 28, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (LGVN) (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and ...

The two-day event brought together a mix of researchers, startup founders and industry professionals in the Maryland life sciences community. Conference panelists. ️ Add Technical.ly to Google Today, ...

Bio-Path Holdings will host a conference call on May 29, 2025, to discuss its business overview and pipeline developments. Bio-Path Holdings, Inc., a biotechnology company focused on developing cancer ...

WALTHAM, Mass., April 8, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and ...

KELOWNA, BC / ACCESS Newswire / June 5, 2025 / Lexaria Bioscience Corp. (LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that its Chief ...